» Articles » PMID: 32943397

Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy: A Single-Center Experience

Overview
Specialty Nephrology
Date 2020 Sep 18
PMID 32943397
Citations 24
Authors
Affiliations
Soon will be listed here.
Citing Articles

Efficacy and safety of low-molecular-weight-heparin plus citrate in nephrotic syndrome during continuous kidney replacement therapy: retrospective study.

Wang D, Yang M, Li S, Tang C, Ai J, Liu D PeerJ. 2025; 13:e18919.

PMID: 40028212 PMC: 11869884. DOI: 10.7717/peerj.18919.


How to safeguard the continuous renal replacement therapy circuit: a narrative review.

Hu C, Shui P, Zhang B, Xu X, Wang Z, Wang B Front Med (Lausanne). 2024; 11:1442065.

PMID: 39234046 PMC: 11373359. DOI: 10.3389/fmed.2024.1442065.


Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy.

Zhu D, He J, Xiao Z, Zhou X, Zhang X Sci Rep. 2024; 14(1):13504.

PMID: 38866989 PMC: 11169537. DOI: 10.1038/s41598-024-64433-6.


Knowledge, attitude, practice, needs, and implementation status of intensive care unit staff toward continuous renal replacement therapy: a survey of 66 hospitals in central and South China.

Yu X, Ouyang L, Li J, Peng Y, Zhong D, Yang H BMC Nurs. 2024; 23(1):281.

PMID: 38671501 PMC: 11055233. DOI: 10.1186/s12912-024-01953-6.


Dialysis resource allocation in critical care: the impact of the COVID-19 pandemic and the promise of big data analytics.

Koraishy F, Mallipattu S Front Nephrol. 2023; 3:1266967.

PMID: 37965069 PMC: 10641281. DOI: 10.3389/fneph.2023.1266967.